Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • City of London BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Mark Kleinman: Share price slump moves Steiner closer to Ocado checkout 

      Mark Kleinman is Sky News' City Editor and writes a column for City AM

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Silverstone safe amid MotoGP calendar shake-up, chiefs insist

      Unfortunately, without any specific context, article title, or content provided, I cannot generate an accurate alt text fo...

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • City AM Puzzles
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      New City venue rethinks competitive socialising… again

      Poolhouse at Square Mile City, Liverpool Street with modern architecture, reflecting vibrant urban development

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Newsletters
  • Latest Paper

Medipharmacy

  • GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn

    Pharma

    Pharma giant GSK has sealed a $10bn deal to snap up Boston-based biopharmaceutical company Nuvalent. The FTSE 100 titan said it will pay $124 per share in cash in the agreement, marking a 40 per cent premium over what Nuvalent’s stock was trading at just before this announcement. The deal is expected to officially close [...]

    GSK logo displayed prominently, signifying the companys presence and relevance in the business and healthcare sectors.
  • Flush FTSE 100 giant Astrazeneca to give more back to shareholders with dividend hike

    pharma

    AstraZeneca will increase its annual dividend for the year by $0.20 (16p) to $3.10 (£2.47) per share

    AstraZeneca will increase its annual dividend for the year by $0.20 (16p) to $3.10 (£2.47) per share
  • NHS pharmacy chain owed £40m before it was bought out of administration

    Administration

    An estimated £40m was owed by NHS pharmacy chain Medipharmacy before it collapsed into administration and was rescued, it has been revealed.

    Medipharmacy operates locations across London and the South East.

Trending Articles

  • Reeves’ new tax charge on cash ISAs faces fierce industry backlash

  • As it happened: Stocks recover after markets rocked by tech-sell off; US claims ‘good foundations’ of Iran deal

  • As it happened: FTSE 100 scrapes into green after Segro’s surge; Oil at pre-war levels after Trump snaps at industry

  • Coca-Cola brings in restructuring lineup over failed Costa sale

  • Treasury confirms scrapping of Lifetime ISA but industry questions remain

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • Got a story?
  • About City AM
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance
  • City AM Events
  • City Winners
  • The Punter
  • Casino
  • City AM Puzzles

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Licensing
Copyright 2026 City AM Limited